I87.2 L97 I70.24 I87.21
Conditions
Interventions
Group 1: Treatment with cold atmospheric plasma:
1 minute per 25cm2 twice weekly for 3 weeks.
Group 2: placebo
Same device, but without generation of cold atmospheric plasma. Procedure identical to
Sponsors
Klinik und Poliklinik für Dermatologie und Allergologie der Universität München
Eligibility
Sex/Gender
All
Age
18 Years to No maximum
Inclusion criteria
Inclusion criteria: All patients capable of giving consent who are undergoing outpatient, inpatient or day-care dermatological treatment with acute or chronic wounds at our clinic.
Exclusion criteria
Exclusion criteria: Patients under care or incapable of giving consent, under-aged (< 18 years).
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| The following endpoints are measured at week 1, 2, 3 and 1 week after the last treatment (follow-up): 1. Change in blood flow/microcirculation as measured by tissue hemoglobin index 2. Change in oxygen supply as measured by oxygen-saturation of the tissue 3. Change in edema as measured by tissue water index 4. Woundpain as measured on a nociceptive scale | — |
Secondary
| Measure | Time frame |
|---|---|
| 1. Quality of life measured by standardized and established questionnaire ("Wound-quality of life", Wound-QoL) (week 1 and 3) 2. Reduction of wound size (week 1, 2, 3 und 1 week after last treatment (follow-up) | — |
Countries
Germany
Contacts
Public ContactJustin Gabriel Schlager
Klinik und Poliklinik für Dermatologie und Allergologie der Universität München
Outcome results
None listed